VarmX

Leiden, The Netherlands

VarmX B.V. is manufacturing therapeutic proteins to instantaneously restore blood clotting in bleeding patients.

$15.8M raised

Feb 2025

Venture - Series Unknown

Top Investors

EQT Life SciencesYsios CapitalInkefEuropean Innovation CouncilBioGeneration Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has VarmX raised?

VarmX has raised $15.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.

Who are VarmX's investors?

VarmX's investors include EQT Life Sciences, Ysios Capital, Inkef, European Innovation Council, BioGeneration Ventures.

Where is VarmX headquartered?

VarmX is headquartered in Leiden, The Netherlands.

What does VarmX do?

VarmX B.V. is manufacturing therapeutic proteins to instantaneously restore blood clotting in bleeding patients.

What stage is VarmX at?

VarmX is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 25, 2025.

MLA

"VarmX — Funding & Investors." VCBacked, February 25, 2025, https://www.vcbacked.co/company/varmx. Accessed June 4, 2026.

APA

VCBacked. (2025). VarmX — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/varmx

Wikipedia (cite web)

{{cite web |title=VarmX — Funding & Investors |url=https://www.vcbacked.co/company/varmx |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 25, 2025.